Draft genome of an Escherichia coli gut isolate from a sertraline-treated patient suggests potential antibiotic resistance induction.
Wallnisch JL, Wünschmann T, Baborski A, Rau M, Refisch A, Opel N, Allen RJ, Busch A 2026 Draft genome of an Escherichia coli gut isolate from a sertraline-treated patient suggests potential antibiotic resistance induction. Microbiol Resour Announc , e0108725.
Abstract
The draft genome of Escherichia coli ADAR08_002, from feces of a patient with major depressive disorder (MDD) treated long-term with sertraline, is 5,247,898 bp (GC 50.65%) in 273 contigs (N50 153,410 bp). It harbors mobile elements and antibiotic resistance, persistence, and metabolic adaptation genes, serving as a resource to study antidepressant impacts.